Samuel N Baldwin1, Shaun L Sandow2, Gema Mondéjar-Parreño3, Jennifer B Stott1, Iain A Greenwood1. 1. Vascular Biology Research Centre, Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom. 2. Biomedical Science, School of Health and Sports Science, University of the Sunshine Coast, Maroochydore, QLD, Australia. 3. Department of Pharmacology and Toxicology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Abstract
Background and Purpose: Arterial diameter is dictated by the contractile state of the vascular smooth muscle cells (VSMCs), which is modulated by direct and indirect inputs from endothelial cells (ECs). Modulators of KCNQ-encoded kV7 channels have considerable impact on arterial diameter and these channels are known to be expressed in VSMCs but not yet defined in ECs. However, expression of kV7 channels in ECs would add an extra level of vascular control. This study aims to characterize the expression and function of KV7 channels within rat mesenteric artery ECs. Experimental Approach: In rat mesenteric artery, KCNQ transcript and KV7 channel protein expression were determined via RT-qPCR, immunocytochemistry, immunohistochemistry and immunoelectron microscopy. Wire myography was used to determine vascular reactivity. Key Results: KCNQ transcript was identified in isolated ECs and VSMCs. KV7.1, KV7.4 and KV7.5 protein expression was determined in both isolated EC and VSMC and in whole vessels. Removal of ECs attenuated vasorelaxation to two structurally different KV7.2-5 activators S-1 and ML213. KIR2 blockers ML133, and BaCl2 also attenuated S-1 or ML213-mediated vasorelaxation in an endothelium-dependent process. KV7 inhibition attenuated receptor-dependent nitric oxide (NO)-mediated vasorelaxation to carbachol, but had no impact on relaxation to the NO donor, SNP. Conclusion and Implications: In rat mesenteric artery ECs, KV7.4 and KV7.5 channels are expressed, functionally interact with endothelial KIR2.x channels and contribute to endogenous eNOS-mediated relaxation. This study identifies KV7 channels as novel functional channels within rat mesenteric ECs and suggests that these channels are involved in NO release from the endothelium of these vessels.
Background and Purpose: Arterial diameter is dictated by the contractile state of the vascular smooth muscle cells (VSMCs), which is modulated by direct and indirect inputs from endothelial cells (ECs). Modulators of KCNQ-encoded kV7 channels have considerable impact on arterial diameter and these channels are known to be expressed in VSMCs but not yet defined in ECs. However, expression of kV7 channels in ECs would add an extra level of vascular control. This study aims to characterize the expression and function of KV7 channels within rat mesenteric artery ECs. Experimental Approach: In rat mesenteric artery, KCNQ transcript and KV7 channel protein expression were determined via RT-qPCR, immunocytochemistry, immunohistochemistry and immunoelectron microscopy. Wire myography was used to determine vascular reactivity. Key Results:KCNQ transcript was identified in isolated ECs and VSMCs. KV7.1, KV7.4 and KV7.5 protein expression was determined in both isolated EC and VSMC and in whole vessels. Removal of ECs attenuated vasorelaxation to two structurally different KV7.2-5 activators S-1 and ML213. KIR2 blockers ML133, and BaCl2 also attenuated S-1 or ML213-mediated vasorelaxation in an endothelium-dependent process. KV7 inhibition attenuated receptor-dependent nitric oxide (NO)-mediated vasorelaxation to carbachol, but had no impact on relaxation to the NO donor, SNP. Conclusion and Implications: In rat mesenteric artery ECs, KV7.4 and KV7.5 channels are expressed, functionally interact with endothelial KIR2.x channels and contribute to endogenous eNOS-mediated relaxation. This study identifies KV7 channels as novel functional channels within rat mesenteric ECs and suggests that these channels are involved in NO release from the endothelium of these vessels.
Authors: Fu Liang Ng; Alison J Davis; Thomas A Jepps; Maksym I Harhun; Shuk Yin Yeung; Andrew Wan; Marcus Reddy; David Melville; Antonio Nardi; Teck K Khong; Iain A Greenwood Journal: Br J Pharmacol Date: 2011-01 Impact factor: 8.739
Authors: T A Mills; S L Greenwood; G Devlin; Y Shweikh; M Robinson; E Cowley; C E Hayward; E C Cottrell; T Tropea; M F Brereton; W Dalby-Brown; M Wareing Journal: Placenta Date: 2015-03-21 Impact factor: 3.481
Authors: Preet S Chadha; Friederike Zunke; Hai-Lei Zhu; Alison J Davis; Thomas A Jepps; Søren P Olesen; William C Cole; James D Moffatt; Iain A Greenwood Journal: Hypertension Date: 2012-02-21 Impact factor: 10.190
Authors: S Y M Yeung; V Pucovský; J D Moffatt; L Saldanha; M Schwake; S Ohya; I A Greenwood Journal: Br J Pharmacol Date: 2007-05-21 Impact factor: 8.739
Authors: Anne Schenzer; Thomas Friedrich; Michael Pusch; Paul Saftig; Thomas J Jentsch; Joachim Grötzinger; Michael Schwake Journal: J Neurosci Date: 2005-05-18 Impact factor: 6.167
Authors: Harry Z E Greenberg; Jian Shi; Kazi S Jahan; Matthew C Martinucci; Steven J Gilbert; W-S Vanessa Ho; Anthony P Albert Journal: Vascul Pharmacol Date: 2016-01-06 Impact factor: 5.773
Authors: Rían W Manville; Kaitlyn E Redford; Jennifer van der Horst; Derk J Hogenkamp; Thomas A Jepps; Geoffrey W Abbott Journal: FASEB J Date: 2022-09 Impact factor: 5.834
Authors: Jing Liu; Elaine L Shelton; Rachelle Crescenzi; Daniel C Colvin; Annet Kirabo; Jianyong Zhong; Eric J Delpire; Hai-Chun Yang; Valentina Kon Journal: Int J Mol Sci Date: 2022-01-27 Impact factor: 6.208